Search Results - "Von Seggern, D J"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery by LI, E, BROWN, S. L, VON SEGGERN, D. J, BROWN, G. B, NEMEROW, G. R

    Published in Gene therapy (01-09-2000)
    “…Current adenoviral (Ad) vectors cannot be targeted to specific cell types due to the widespread distribution of the Ad receptor (CAR). Moreover, CAR and/or…”
    Get full text
    Journal Article
  2. 2

    Adenovirus Type 5 Viral Particles Pseudotyped with Mutagenized Fiber Proteins Show Diminished Infectivity of Coxsackie B-Adenovirus Receptor-Bearing Cells by Jakubczak, J L, Rollence, M L, Stewart, D A, Jafari, J D, Von Seggern, D J, Nemerow, G R, Stevenson, S C, Hallenbeck, P L

    Published in Journal of Virology (01-03-2001)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  3. 3

    Inhibition of Radiation Cataractogenesis by WR-77913 by Livesey, J. C., Wiens, L. W., Von Seggern, D. J., Barlow, W. E., Arnold, A. M.

    Published in Radiation research (01-01-1995)
    “…The radioprotective drug S-3-amino-2-hydroxypropylphosphorothioic acid (WR-77913) has been tested as an inhibitor of radiation cataractogenesis. Animals…”
    Get full text
    Journal Article
  4. 4

    Ablating Adenovirus Type 5 Fiber–CAR Binding and HI Loop Insertion of the SIGYPLP Peptide Generate an Endothelial Cell-Selective Adenovirus by Nicklin, Stuart A., Von Seggern, Dan J., Work, Lorraine M., Pek, Don C.K., Dominiczak, Anna F., Nemerow, Glen R., Baker, Andrew H.

    Published in Molecular therapy (01-12-2001)
    “…Adenovirus type 5 (Ad) based vectors transduce vascular endothelial cells (EC) and have been widely used for vascular gene transfer. However, many cell types…”
    Get full text
    Journal Article
  5. 5

    Adenovirus Vector Pseudotyping in Fiber-Expressing Cell Lines: Improved Transduction of Epstein-Barr Virus-Transformed B Cells by Von Seggern, D J, Huang, S, Fleck, S K, Stevenson, S C, Nemerow, G R

    Published in Journal of Virology (01-01-2000)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  6. 6

    A Helper-Independent Adenovirus Vector with E1, E3, and Fiber Deleted: Structure and Infectivity of Fiberless Particles by Von Seggern, D J, Chiu, C Y, Fleck, S K, Stewart, P L, Nemerow, G R

    Published in Journal of Virology (01-02-1999)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7

    Structural Analysis of a Fiber-Pseudotyped Adenovirus with Ocular Tropism Suggests Differential Modes of Cell Receptor Interactions by Chiu, C Y, Wu, E, Brown, S L, Von Seggern, D J, Nemerow, G R, Stewart, P L

    Published in Journal of Virology (01-06-2001)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  8. 8

    Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein by Von Seggern, DJ, Kehler, J, Endo, RI, Nemerow, GR

    Published in Journal of general virology (01-06-1998)
    “…DJ Von Seggern, J Kehler, RI Endo and GR Nemerow Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA. Adenovirus-based gene…”
    Get full text
    Journal Article
  9. 9

    A 50-kDa Membrane Protein Mediates Sialic Acid-Independent Binding and Infection of Conjunctival Cells by Adenovirus Type 37 by Wu, Eugene, Fernandez, Joan, Fleck, Shonna Kaye, Von Seggern, Dan J., Huang, Shuang, Nemerow, Glen R.

    Published in Virology (New York, N.Y.) (05-01-2001)
    “…The ocular tropism of adenovirus type 37 (Ad37) does not correlate with the wide distribution of the 46-kDa coxsackievirus and adenovirus receptor (CAR), the…”
    Get full text
    Journal Article
  10. 10

    Membrane Cofactor Protein Is a Receptor for Adenoviruses Associated with Epidemic Keratoconjunctivitis by WU, Eugene, TRAUGER, Sunia A, PACHE, Lars, MULLEN, Tina-Marie, VON SEGGERN, Daniel J, SIUZDAK, Gary, NEMEROW, Glen R

    Published in Journal of Virology (01-04-2004)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    Flexibility of the Adenovirus Fiber Is Required for Efficient Receptor Interaction by Wu, Eugene, Pache, Lars, Von Seggern, Dan J, Mullen, Tina-Marie, Mikyas, Yeshi, Stewart, Phoebe L, Nemerow, Glen R

    Published in Journal of Virology (01-07-2003)
    “…Erratum ( vol. 78 , p. 2167 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious…”
    Get full text
    Journal Article
  12. 12

    Development of Efficient Viral Vectors Selective for Vascular Smooth Muscle Cells by Work, Lorraine M, Nicklin, Stuart A, Brain, Nick J.R, Dishart, Kate L, Von Seggern, Dan J, Hallek, Michael, Büning, Hildegard, Baker, Andrew H

    Published in Molecular therapy (01-02-2004)
    “…The vascular smooth muscle cell (SMC) is integral to the pathogenesis of neointimal formation associated with late vein graft failure, in-stent restenosis, and…”
    Get full text
    Journal Article
  13. 13

    Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo by Denby, Laura, Work, Lorraine M, Graham, Delyth, Hsu, Catherine, von Seggern, Dan J, Nicklin, Stuart A, Baker, Andrew H

    Published in Human gene therapy (01-11-2004)
    “…Adenovirus (Ad5) serotype 5 vectors are commonly used for gene transfer. Preclinical studies have shown that their application to systemic gene delivery,…”
    Get more information
    Journal Article
  14. 14

    In vitro and in vivo characterisation of endothelial cell selective adenoviral vectors by Nicklin, Stuart A., White, Steve J., Nicol, Campbell G., Von Seggern, Dan J., Baker, Andrew H.

    Published in The journal of gene medicine (01-03-2004)
    “…Background Both viral and non‐viral gene transfer vectors transduce vascular endothelial cells (EC) with low efficiency compared with other cell types such as…”
    Get full text
    Journal Article
  15. 15

    In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity by Hsu, Catherine, Boysen, Megan, Gritton, Lance D., Frosst, Phyllis D., Nemerow, Glen R., Von Seggern, Dan J.

    Published in Virology (New York, N.Y.) (05-02-2005)
    “…Expression of antigens in dendritic cells (DC) can stimulate protective immunity against both viral infection and tumor growth, making them important targets…”
    Get full text
    Journal Article
  16. 16

    Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectors by Nicklin, Stuart A., Dishart, Kate L., Buening, Hildegard, Reynolds, Paul N., Hallek, Michael, Nemerow, Glen R., Von Seggern, Dan J., Baker, Andrew H.

    Published in Cancer letters (25-11-2003)
    “…Gene delivery vectors, including adenovirus (Ad) and adeno-associated virus (AAV), are inefficient and non-selective for cancer due to low levels of viral…”
    Get full text
    Journal Article
  17. 17

    In vivo transduction of photoreceptors or ciliary body by intravitreal injection of pseudotyped adenoviral vectors by Von Seggern, Dan J, Aguilar, Edith, Kinder, Karen, Fleck, Shonna Kaye, Gonzalez Armas, J.C, Stevenson, Susan C, Ghazal, Peter, Nemerow, Glen R, Friedlander, Martin

    Published in Molecular therapy (01-01-2003)
    “…Strategies for retargeting adenoviral (Ad) vectors have been developed, but their in vivo efficacy remains to be demonstrated. Gene delivery to specific ocular…”
    Get full text
    Journal Article
  18. 18